- Home
- ZEPP vs SIGA Comparison
ZEPP vs SIGA Comparison
Compare ZEPP & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZEPP
- SIGA
- Stock Information
- Founded
- ZEPP 2013
- SIGA 1995
- Country
- ZEPP Netherlands
- SIGA United States
- Employees
- ZEPP N/A
- SIGA N/A
- Industry
- ZEPP Computer Manufacturing
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- ZEPP Technology
- SIGA Health Care
- Exchange
- ZEPP Nasdaq
- SIGA Nasdaq
- Market Cap
- ZEPP 696.3M
- SIGA 594.3M
- IPO Year
- ZEPP N/A
- SIGA 1997
- Fundamental
- Price
- ZEPP $41.36
- SIGA $8.49
- Analyst Decision
- ZEPP
- SIGA
- Analyst Count
- ZEPP 0
- SIGA 0
- Target Price
- ZEPP N/A
- SIGA N/A
- AVG Volume (30 Days)
- ZEPP 249.4K
- SIGA 373.6K
- Earning Date
- ZEPP 11-04-2025
- SIGA 11-06-2025
- Dividend Yield
- ZEPP N/A
- SIGA 7.14%
- EPS Growth
- ZEPP N/A
- SIGA N/A
- EPS
- ZEPP N/A
- SIGA 1.14
- Revenue
- ZEPP $199,947,000.00
- SIGA $179,639,422.00
- Revenue This Year
- ZEPP $851.79
- SIGA N/A
- Revenue Next Year
- ZEPP $14.33
- SIGA $115.06
- P/E Ratio
- ZEPP N/A
- SIGA $7.37
- Revenue Growth
- ZEPP N/A
- SIGA 3.86
- 52 Week Low
- ZEPP $2.13
- SIGA $4.95
- 52 Week High
- ZEPP $61.85
- SIGA $9.62
- Technical
- Relative Strength Index (RSI)
- ZEPP 38.51
- SIGA 49.48
- Support Level
- ZEPP $49.10
- SIGA $8.07
- Resistance Level
- ZEPP $56.28
- SIGA $8.54
- Average True Range (ATR)
- ZEPP 5.27
- SIGA 0.26
- MACD
- ZEPP -1.81
- SIGA -0.01
- Stochastic Oscillator
- ZEPP 1.66
- SIGA 83.05
About ZEPP Zepp Health Corporation
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.